Citi downgrades Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) to a Hold
I'm LongbridgeAI, I can summarize articles.Citi analyst Laura Sutcliffe downgraded ResMed Inc CHESS Depositary Interests to a Hold with an A$34.00 price target. This follows Morgan Stanley's mixed ratings, maintaining a Buy while David Bailey issued a Hold on July 8. Sutcliffe, covering the Healthcare sector, has a 52.05% success rate.
Citi analyst Laura Sutcliffe downgraded Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh to a Hold today and set a price target of A$34.00.
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
According to TipRanks, Sutcliffe is a 3-star analyst with an average return of 1.7% and a 52.05% success rate. Sutcliffe covers the Healthcare sector, focusing on stocks such as Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, CSL, and Telix Pharmaceuticals.
In addition to Citi, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh also received a Hold from Morgan Stanley’s David Bailey in a report issued on July 8. However, on the same day, Morgans maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (ASX: RMD).